Pinnacle Bancorp, Inc. Horizon Therapeutics Public LTD CO Transaction History

Pinnacle Bancorp, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 24, 2023	SELL	$62.39 - $113.8 $6,800 - $12,404	-109 Reduced 56.77%	83 $9,000
Q1 2022 Apr 14, 2022	BUY	$86.42 - $109.81 $2,679 - $3,404	31 Added 19.25%	192 $20,000
Q4 2021 Jan 19, 2022	BUY	$98.56 - $119.91 $1,872 - $2,278	19 Added 13.38%	161 $17,000
Q2 2021 Jul 15, 2021	BUY	$86.24 - $95.92 $12,246 - $13,620	142 New	142 $13,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Pinnacle Bancorp, Inc., based on Form 13F filings with the SEC.

Stay updated on Pinnacle Bancorp, Inc. with notifications on news.